Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

62
S&P 500 'Safer' Dividend Stocks Yield 4.2% To 6% For June

2018-06-08 seekingalpha
35 of 90 S&P 500 Index top-yield dividend stocks were labeled as "safer" for dividends because they showed positive one-year returns, and free cash-flow yields greater than their dividend-yields 6/5/18.
REG DLR.PRH DLR.PRG PM DLR.PRJ DLR.PRI PFG O.PRF MET STX OPRF PRU VZA PM WELL LEG PAYX VTR PRU REG.PRG REG.PRF PFK O SPG.PRJ PEP PRH CVX VZ DLR SPG QCOM DLR.PRC DLR.PRF PJH IVZ

564
Tracking Yacktman Asset Management Portfolio - Q1 2018 Update

2018-05-10 seekingalpha
This article is part of a series that provides an ongoing analysis of the changes made to Yacktman's 13F stock portfolio on a quarterly basis. It is based on Yacktman Asset Management's regulatory 13F Form filed on 05/09/2018. Please visit our Tracking Yacktman Asset Management series to get an idea of his investment philosophy and our previous update for the fund's moves during Q4 2017.
ATHTF SYY XOM ULVR AVP RDI CHRW UNLNF HPE UHAL VIAB SYK CSCO CMCSK ABBV MMM CRMT MO FOX STT GLW NWS NWSA UNLYF INFY CTSH BRK.A JNJ BK MSFT ABBV CLX FOXA ESRX WFCNP PM MTSI PG STT.PRC CCV STT.PRE STT.PRD STT.PRG WFC.PRL CCZ WFC.PRJ USB COP BAC WFC.PRT GS WFC.PRR OTEL RDIB WFC.PRQ PM WFC.PRP NWS WFC.PRO WFC.PRN KO WFC.PRY WFC.PRX WFC.PRW ORCL DIS WFC.PRV WFC WFC.WS GJV UL UN CMCSA ANTM PEP CCV.CL OCLCF HPQ ANTX

60
S&P 500 'Safer' Dividend Stock Yield Leaders Are Welltower, Ventas, & Ford For May

2018-05-06 seekingalpha
46 of 114 S&P 500 Index top-yield dividend stocks were labeled as "safer" for dividends because they showed positive one-year returns, and free cash-flow yields greater than their dividend-yields 5/3/18.
PM PFG O.PRF MET STX OPRF PRU ETN VZA PM IP WELL LEG VTR PRU INPAP PFK O SPG.PRJ PEP PRH VZ SPG QCOM PJH IVZ

27
40 Largest Companies Reporting Earnings Next Week | Bespoke Investment Group

2018-04-13 bespokepremium
Below is a snapshot of the 40 largest companies set to report earnings next week. For each stock, we show its current consensus EPS and revenue estimate, and we also show each stock’s historical EPS and revenue beat rate. (Additional earnings season info is available with a Bespoke Premium free trial.)
SCHW.PRBCL GEC GE MS.PRE MS.PRF MS.PRG MS.PRA PM MS.PRI PPG MS.PRK GNE MS

46
S&P 500 'Safer' Dividend Gains Led By General Motors, Qualcomm, And Invesco For March

2018-03-16 seekingalpha
19 of 81 S&P 500 Index top-yield dividend stocks were labeled as "safer" for dividends because they showed positive one-year returns, and free cash-flow yields greater than their dividend-yields 3/13/18.
PM MET STX PM SPG.PRJ GM.WS.A GM.WS.B GM.WS.C KSS SPG GM HST QCOM FE GM.WSB PFE IVZ

46
S&P 500 'Safer' Dividend Gains Led By General Motors, Qualcom, & Invesco For March

2018-03-16 seekingalpha
19 of 81 S&P 500 Index top-yield dividend stocks were labeled as "safer" for dividends because they showed positive one-year returns, and free cash-flow yields greater than their dividend-yields 3/13/18.
PM MET STX PM SPG.PRJ GM.WS.A GM.WS.B GM.WS.C KSS SPG GM HST QCOM FE GM.WSB PFE IVZ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:PM / PHILIP MORRIS INTL on message board site Silicon Investor.

Wennerstrom Semi Equipment Analysis J.P. Morgan Chase (JPM)
Free Float Trading/ Portfolio Development/ Index Stategies RPM, Inc. (RPOW)
PMX.V - ProAm Exploration Corp WrapMail
PMC-Sierra (PMCS) EWPMF East West Petroleum
EWPMF East West Petroleum ChipMOS